CIPLA
|
The Current P/B Ratio of CIPLA is 4.65.
Share Price | ₹1,345.4 | Apr 19,2024 |
Market Cap | ₹108,623.6 Cr | |
Book Value | ₹23,346.0 Cr | Mar2023 - Consolidated Results |
Price/Book | 4.65x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of CIPLA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹108,623.6 Cr] as on Apr 19,2024
(/) Book Value [ ₹23,346.0 Cr] based on Mar2023 - Consolidated Results
(=) P/B Ratio [ 4.65x ]
Thus, for CIPLA , the investors are currently willing to pay '4.65 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !
The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.
Historical PB (Price/Book ) ratio chart of CIPLA
PB Ratio Performance Analysis for CIPLA
- CIPLA 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 3.14x.
- CIPLA 's operated at median p/b ratio of 3.11x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2022 at 3.95x.
- CIPLA 's p/b ratio hit its five-year low in Mar2020 of 2.17x.
How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
CIPLA | 23,346.00 | 4.65 | 108,623.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.52 | 365,311.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.28 | 99,134.3 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.30 | 92,794.9 |
DIVIS LABORATORIES LTD | 12,767.10 | 7.63 | 97,408.4 |
MANKIND PHARMA LTD | 7,435.16 | 12.58 | 93,565.4 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 13.85 | 85,858.5 |
LUPIN LTD | 12,315.60 | 5.72 | 70,506.8 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.37 | 63,697.4 |
ABBOTT INDIA LTD | 3,146.02 | 17.65 | 55,528.4 |
ALKEM LABORATORIES LTD | 9,044.69 | 6.09 | 55,102.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.37x |
Max industry PB | 17.65x |
Median industry PB | 6.09x |
Average industry PB | 7.88x |
You may also like the below Video Courses